Moreover, when ATXN2 was upregulated, the IC50 (for 5-FU) of SGC7901 cells increased; when ATXN2 was downregulated, the IC50 (for 5-FU) of drug-resistant GC cells decreased (Figure 2(d)). Here, ATXN2 is linked to gastric cancer.